Condition
Extramedullary Disease in Multiple Myeloma clinical trials and research
Research outlook What's coming for Multiple myeloma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Extramedullary Disease in Multiple Myeloma clinical trials that are recruiting, in United States. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Low-dose radiation to boost elranatamab for relapsed/refractory multiple myeloma with extramedullary or paramedullary disease
We will test whether low-dose radiation given before elranatamab helps people with relapsed or refractory multiple myeloma that has grown outside the bone or into surrounding tissue respond better to treatment.
-
Treatment for relapsed or refractory multiple myeloma with extramedullary disease
This study is testing a new combination of medications to see if it can help people with relapsed or hard-to-treat multiple myeloma that has spread outside the bone marrow.
Related topics
Quick answers
How many Extramedullary Disease in Multiple Myeloma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.